Detalles de la búsqueda
1.
Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO Registry.
Ann Rheum Dis
; 72(1): 79-82, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22945500
2.
Impact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registry.
Ann Rheum Dis
; 72(1): 57-63, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22532636
3.
Establishment of age- and sex-adjusted reference data for hand bone mass and investigation of hand bone loss in patients with rheumatoid arthritis treated in clinical practice: an observational study from the DANBIO registry and the Copenhagen Osteoarthritis Study.
Arthritis Res Ther
; 18: 53, 2016 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-26912229
4.
Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
J Rheumatol
; 41(12): 2352-60, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25274894
5.
Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.
Arthritis Rheum
; 62(1): 22-32, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20039405
Resultados
1 -
5
de 5
1
Próxima >
>>